Catalyst Wire Dossier Catalyst Wire Dossier

NIRx Paclitaxel-Coated Conformer Coronary Stent

paclitaxel-coated conformer coronary stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NIRx Paclitaxel-Coated Conformer Coronary Stent, covering 2017-03-03 to 2017-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent [Phase 2]

See pricing